$130M
The Series C financing was led by Leaps by Bayer and Hitachi Ventures to support international expansion and platform development.
Huma Therapeutics
Huma Therapeutics develops a modular digital health platform for virtual hospital care and decentralized clinical trials.
$130MTotal raised
Huma Therapeutics provides a digital health platform that powers virtual hospitals at home and supports decentralized clinical trials. The modular technology combines predictive algorithms and real-world data to advance proactive care.
Categories
Team
AM
Alan Milburn
Chairman of Huma’s Board
CS
Claudia Suessmuth Dyckerhoff
Huma Board Director